Overview
Anna Salas practices practicing medicine in Barcelona, Spain.
Her clinical expertise encompasses Late-Onset Retinal Degeneration, Age-Related Macular Degeneration (ARMD), and Diabetic Retinopathy.
She is actively involved in clinical research, co-authoring 8 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Anna Salas
Is Anna Salas a top-rated expert for Late-Onset Retinal Degeneration?
MediFind is an objective health platform that identifies experts based on real-world data. Anna Salas is classified as an Experienced expert for Late-Onset Retinal Degeneration, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Anna Salas participate in research or clinical trials?
Yes. Anna Salas has published 8 articles and abstracts on conditions like Late-Onset Retinal Degeneration. You can view a list of Anna Salas's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Age-Related Macular Degeneration (ARMD)
- Diabetic RetinopathyMs. Salas isExperienced. Learn about Diabetic Retinopathy.
- Late-Onset Retinal DegenerationMs. Salas isExperienced. Learn about Late-Onset Retinal Degeneration.